{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:49:33Z","timestamp":1792021773111,"version":"4.4.0"},"reference-count":20,"publisher":"American Veterinary Medical Association (AVMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["javma"],"published-print":{"date-parts":[[2018,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p><jats:bold>CASE DESCRIPTION<\/jats:bold> A 9-year-old 8.3-kg (18.3-lb) neutered male Miniature Schnauzer was referred for diagnosis and treatment of a sudden onset of lethargy, anorexia, vomiting, and pallor.<\/jats:p>\n<jats:p><jats:bold>CLINICAL FINDINGS<\/jats:bold> On physical examination, the dog was lethargic with pale mucous membranes and a capillary refill time \u2265 2 seconds. Skin and sclera were mildly icteric. Signs of pain were elicited during abdominal palpation, and an enlarged spleen was noted. Results of agglutination testing and cytologic findings were consistent with immune-mediated hemolytic anemia (IMHA). No contributing factors for development of IMHA were identified.<\/jats:p>\n<jats:p><jats:bold>TREATMENT AND OUTCOME<\/jats:bold> Initial treatment included management with immunosuppressant medications. Three packed RBC transfusions were administered, but clinical signs continued to progress. Therefore, therapeutic plasma exchange (TPE) was performed 5 and 9 days after admission. Following each TPE procedure, the dog had an appreciable clinical improvement and decrease in RBC autoagglutination, and the Hct stabilized. Serum IgG and IgM concentrations were measured during and after both TPE procedures. Despite anticoagulative treatment, the dog developed a thrombus in the splenic vein, necessitating a splenectomy.<\/jats:p>\n<jats:p><jats:bold>CLINICAL RELEVANCE<\/jats:bold> The decrease and rebound in serum IgG and IgM concentrations following TPE provided evidence that TPE may have the same immunomodulatory effects in dogs as have been proposed to occur in people. Further, findings suggested that TPE may be a useful alternative in dogs with refractory IMHA when traditional treatments fail.<\/jats:p>","DOI":"10.2460\/javma.252.9.1108","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T19:52:41Z","timestamp":1523476361000},"page":"1108-1112","source":"Crossref","is-referenced-by-count":21,"title":["Effects of therapeutic plasma exchange on serum immunoglobulin concentrations in a dog with refractory immune-mediated hemolytic anemia"],"prefix":"10.2460","volume":"252","author":[{"given":"Alyssa M.","family":"Scagnelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Acierno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"Am J Kidney Dis","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1053\/j.ajkd.2008.02.360","article-title":"Therapeutic plasma exchange: core curriculum 2008","volume":"52","author":"Kaplan","year":"2008"},{"key":"ref2","series-title":"Am J Kidney Dis","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0272-6386(12)80135-1","article-title":"Therapeutic plasma exchange: complications and management","volume":"23","author":"Mokrzycki","year":"1994"},{"key":"ref3","series-title":"Hematology Am Soc Hematol Educ Program","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/asheducation.V2012.1.7.3797920","article-title":"Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines","volume":"2012","author":"Winters","year":"2012"},{"key":"ref4","series-title":"Am J Vet Res","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2460\/ajvr.68.6.657","article-title":"Response of healthy dogs to infusions of human serum albumin","volume":"68","author":"Cohn","year":"2007"},{"key":"ref5","series-title":"J Vet Emerg Crit Care (San Antonio)","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/vec.12208","article-title":"Hydroxyethyl starch: a review of pharmacokinetics, pharmacodynamics, current products, and potential clinical risks, benefits, and use","volume":"24","author":"Glover","year":"2014"},{"key":"ref6","series-title":"J Vet Emerg Crit Care (San Antonio)","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1476-4431.2009.00431.x","article-title":"Use of therapeutic plasmapheresis in a case of canine immune-mediated hemolytic anemia","volume":"19","author":"Crump","year":"2009"},{"key":"ref7","series-title":"Compend Contin Educ Vet","first-page":"264","article-title":"Continuous renal replacement therapy","volume":"30","author":"Acierno","year":"2008"},{"key":"ref8","series-title":"Ther Apher Dial","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1526-0968.2003.00004.x","article-title":"Plasmapheresis in immune hematology: review of clinical outcome data with respect to evidence-based medicine and clinical experience","volume":"7","author":"von Baeyer","year":"2003"},{"key":"ref9","series-title":"Pediatr Nephrol","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00467-013-2479-7","article-title":"Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013","volume":"29","author":"Carter","year":"2014"},{"key":"ref10","series-title":"Ther Apher Dial","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/1744-9987.12353","article-title":"Therapeutic apheresis: why?","volume":"19","author":"Malchesky","year":"2015"},{"key":"ref11","series-title":"Neurocrit Care","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12028-009-9274-0","article-title":"Immunomodulatory therapies in neurologic critical care","volume":"12","author":"McDaneld","year":"2010"},{"issue":"suppl 5","key":"ref12","series-title":"Nephrol Dial Transplant","article-title":"Current applications of plasmapheresis in clinical toxicology","volume":"18","author":"Nenov","year":"2003"},{"key":"ref13","series-title":"Ther Apher","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1046\/j.1526-0968.2001.00316.x","article-title":"Membrane plasmapheresis in the United States: a review over the last 20 years","volume":"5","author":"Siami","year":"2001"},{"key":"ref14","series-title":"Blood Transfus","first-page":"164","article-title":"Removal kinetics of therapeutic apheresis","volume":"5","author":"Reverberi","year":"2007"},{"key":"ref15","series-title":"Clin J Am Soc Nephrol","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2215\/CJN.04680513","article-title":"Mini-review principles of separation: indications and therapeutic targets for plasma exchange","volume":"9","author":"Williams","year":"2014"},{"key":"ref16","series-title":"Clin Exp Immunol","first-page":"32","article-title":"Specific suppression of antibody rebound after extracorporeal immunoadsorption","volume":"34","author":"Terman","year":"1978"},{"key":"ref17","series-title":"J Am Vet Med Assoc","first-page":"1276","article-title":"Clinical remission following plasmapheresis and corticosteroid treatment in a dog with acquired myasthenia gravis","volume":"196","author":"Bartges","year":"1990"},{"key":"ref18","series-title":"J Small Anim Pract","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1748-5827.2011.01024.x","article-title":"Immunomodulatory drugs and their application to the management of canine immune-mediated disease","volume":"52","author":"Whitley","year":"2011"},{"key":"ref19","series-title":"J Am Vet Med Assoc","first-page":"595","article-title":"Plasmapheresis in five dogs with systemic immune-mediated disease","volume":"187","author":"Matus","year":"1985"},{"key":"ref20","series-title":"J Am Vet Med Assoc","first-page":"691","article-title":"Plasmapheresis as adjuvant therapy for autoimmune hemolytic anemia in two dogs","volume":"186","author":"Matus","year":"1985"}],"container-title":["Journal of the American Veterinary Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/252\/9\/javma.252.9.1108.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/252\/9\/javma.252.9.1108.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/252\/9\/javma.252.9.1108.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T11:59:34Z","timestamp":1741348774000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/252\/9\/javma.252.9.1108.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":20,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.2460\/javma.252.9.1108","relation":{},"ISSN":["0003-1488"],"issn-type":[{"value":"0003-1488","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,1]]}}}